ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | – | 1,056 | +162.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 403 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 403 | -58.2% | 0.00% | – |
| Q4 2021 | $3,000 | +200.0% | 964 | +221.3% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 300 | +56.2% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 192 | +8.5% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 177 | -42.7% | 0.00% | – |
| Q2 2020 | $1,000 | -50.0% | 309 | -21.6% | 0.00% | – |
| Q1 2020 | $2,000 | -60.0% | 394 | -43.8% | 0.00% | – |
| Q3 2019 | $5,000 | +150.0% | 701 | +645.7% | 0.00% | – |
| Q2 2019 | $2,000 | – | 94 | +154.1% | 0.00% | – |
| Q1 2019 | $0 | – | 37 | -77.8% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 167 | -16.1% | 0.00% | – |
| Q3 2017 | $2,000 | – | 199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 4,898,927 | $6,246,132 | 0.70% |
| Yakira Capital Management, Inc. | 620,019 | $790,524 | 0.22% |
| Crystalline Management Inc. | 230,817 | $294,292 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 475,000 | $605,625 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,283,979 | $2,912,073 | 0.12% |
| PenderFund Capital Management Ltd. | 123,444 | $213 | 0.06% |
| FIFTH LANE CAPITAL, LP | 100,000 | $127,000 | 0.04% |
| CSS LLC/IL | 476,831 | $607,960 | 0.04% |
| Penserra Capital Management LLC | 220,858 | $280 | 0.01% |
| King Wealth Management Group | 16,000 | $20 | 0.00% |